Concord Wealth Partners - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2022$12,000
-36.8%
813
-42.5%
0.00%
-40.0%
Q4 2021$19,000
+72.7%
1,414
+108.6%
0.01%0.0%
Q3 2021$11,000
-59.3%
678
-57.2%
0.01%
-37.5%
Q2 2021$27,000
-12.9%
1,585
-7.4%
0.01%
-20.0%
Q1 2021$31,000
+63.2%
1,712
+61.7%
0.01%
-33.3%
Q4 2020$19,0001,0590.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders